← 返回首页
美国 · 平台与数据 · MarketBeat

Axsome Therapeutics Sees AUVELITY Prescription Surge After Alzheimer’s Agitation Launch

来源:MarketBeat · 美国 33 分钟前
Image from MarketBeat Media, LLC.
Image from MarketBeat Media, LLC. · MarketBeat

详细摘要

Axsome Therapeutics (NASDAQ:AXSM) executives said growth in new prescriptions for AUVELITY and an expanded sales team are positioning the company for further growth following the drug’s launch for Alzheimer’s disease agitation. Speaking at the UBS Biopharma Conference in London, Chief Financial Off

在 MarketBeat 阅读全文 登录后可收藏

MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.marketbeat.com)

推荐阅读